Key facts
- It has raised $2.6M; the latest was Angel (individual) ($2.0M) in Jun 2025.
- Notable investors include MedTech Innovator, Texas Medical Center, Nordic Mentor Network For Entrepreneurship, BioInnovation Institute, Danish Tech Challenge.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Droplet IV
- ·The full record, as it builds
Funding rounds
No funding rounds for Droplet IV are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Droplet IV
Developer of a medical device designed to improve patients' outcomes and reduce nursing workloads. The company's product automatically flushes every set at the precise time of medicine termination, ensuring patients' optimal treatment quality, enabling patients to get medication using a simple, safe, cost-effective solution.
- Sector
- Healthcare
- HQ
- Copenhagen, Denmark
- Founded
- 2022
- Employees
- 10
- Website
- dropletiv.com/
- Ownership
- Privately Held (backing)
Droplet IV doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Droplet IV shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Droplet IV in its N-PORT filings yet. We sweep new filings monthly.